|
|
| Author |
Message |
Susan
medicine forum Guru
Joined: 05 May 2005
Posts: 932
|
 Posted: Wed May 17, 2006 2:37 pm Post subject:
Maybe one day we'll be able to trust journal editors?
|
|
|
x-no-archive: yes
http://www.medscape.com/viewarticle/532326?sssdmh=dm1.193479&src=nldne
""In order for the articles in medical journals to be free of advertiser
influence, there cannot be continued reliance on pharmaceutical
companies as the sole advertisers," Dr. Adriane Fugh-Berman of the
Georgetown University School of Medicine in Washington, DC, the study's
lead author, told Reuters Health."
Susan |
|
| Back to top |
|
 |
William Wagner
medicine forum Guru
Joined: 29 Apr 2005
Posts: 809
|
| Posted: Wed May 17, 2006 2:49 pm Post subject:
Re: Maybe one day we'll be able to trust journal editors?
|
|
|
In article <4d0qpqF186bnrU1@individual.net>,
Susan <nevermind@nomail.com> wrote:
| Quote: | x-no-archive: yes
http://www.medscape.com/viewarticle/532326?sssdmh=dm1.193479&src=nldne
""In order for the articles in medical journals to be free of advertiser
influence, there cannot be continued reliance on pharmaceutical
companies as the sole advertisers," Dr. Adriane Fugh-Berman of the
Georgetown University School of Medicine in Washington, DC, the study's
lead author, told Reuters Health."
Susan
|
Another nail.
Whole info here.
http://www.medpagetoday.com/PublicHealthPolicy/HealthPolicy/tb/3306
Bill
.................
http://www.medpagetoday.com/PublicHealthPolicy/HealthPolicy/tb/3306
BOSTON, May 16 When a drug company or device-maker is funding a
clinical trial for a new cardiovascular treatment, the reported outcome
is likely to reveal good news for the new treatment, according to
researchers here.
Likewise when funding comes from non-profit sources, the outcomes are
less likely to favor the new treatments and when for-profit and
not-for-profit funders split the tab, the results are, in the words of
Goldilocks, "just right."
Moreover, when a trial uses a surrogate endpoint rather than a clinical
endpoint, the results are likely to favor the new treatments regardless
of who is paying for the research, wrote Paul M. Ridker, M.D., and Jose
Torres of Harvard Medical School in the May 17 issue of the Journal of
the American Medical Association.
That findings emerged from an analysis of outcomes from 324 consecutive
superiority trials of cardiovascular medicine that were published from
Jan. 1, 2000 through July 30, 2005 in JAMA, The Lancet or the New
England Journal of Medicine. Twenty-one trials cited no funding source,
104 were funded solely by not-for-profit entities, 137 were funded by
for-profit organizations, and 62 received joint funding (for-profit and
not-for-profit).
BOSTON, May 16 When a drug company or device-maker is funding a
clinical trial for a new cardiovascular treatment, the reported outcome
is likely to reveal good news for the new treatment, according to
researchers here.
Likewise when funding comes from non-profit sources, the outcomes are
less likely to favor the new treatments and when for-profit and
not-for-profit funders split the tab, the results are, in the words of
Goldilocks, "just right."
Moreover, when a trial uses a surrogate endpoint rather than a clinical
endpoint, the results are likely to favor the new treatments regardless
of who is paying for the research, wrote Paul M. Ridker, M.D., and Jose
Torres of Harvard Medical School in the May 17 issue of the Journal of
the American Medical Association.
That findings emerged from an analysis of outcomes from 324 consecutive
superiority trials of cardiovascular medicine that were published from
Jan. 1, 2000 through July 30, 2005 in JAMA, The Lancet or the New
England Journal of Medicine. Twenty-one trials cited no funding source,
104 were funded solely by not-for-profit entities, 137 were funded by
for-profit organizations, and 62 received joint funding (for-profit and
not-for-profit).
http://www.medpagetoday.com/PublicHealthPolicy/HealthPolicy/tb/3306
--
S Jersey USA Zone 5 Shade
This article is posted under fair use rules in accordance with
Title 17 U.S.C. Section 107, and is strictly for the educational
and informative purposes. This material is distributed without profit. |
|
| Back to top |
|
|
nospam7@heartmdphd.com
medicine forum Guru
Joined: 27 Dec 2005
Posts: 470
|
| Posted: Wed May 17, 2006 4:47 pm Post subject:
Re: Maybe one day we'll be able to trust journal editors?
|
|
|
Susan wrote:
| Quote: |
http://www.medscape.com/viewarticle/532326?sssdmh=dm1.193479&src=nldne
""In order for the articles in medical journals to be free of advertiser
influence, there cannot be continued reliance on pharmaceutical
companies as the sole advertisers," Dr. Adriane Fugh-Berman of the
Georgetown University School of Medicine in Washington, DC, the study's
lead author, told Reuters Health."
|
This proves that the only Person you can trust is LORD GOD Almighty.
Still praying for your soul, dear Susan.
Prayerfully in Christ's amazing love,
Andrew
http://tinyurl.com/mpuzr |
|
| Back to top |
|
|
Cardinal Numbaz
medicine forum Guru
Joined: 05 Dec 2005
Posts: 323
|
| Posted: Thu May 18, 2006 1:27 pm Post subject:
Re: Maybe one day we'll be able to trust journal editors?
|
|
|
Andrew B. Chung, MD/PhD wrote:
| Quote: | Susan wrote:
http://www.medscape.com/viewarticle/532326?sssdmh=dm1.193479&src=nldne
""In order for the articles in medical journals to be free of advertiser
influence, there cannot be continued reliance on pharmaceutical
companies as the sole advertisers," Dr. Adriane Fugh-Berman of the
Georgetown University School of Medicine in Washington, DC, the study's
lead author, told Reuters Health."
This proves that the only Person you can trust is LORD GOD Almighty.
|
No, it proves that those who make money out of the treatment of the
sick have an inherent conflict of interest. That's all. No Lord
required, which is a good thing as there has never been any evidence to
suggest he exists. |
|
| Back to top |
|
|
nospam7@heartmdphd.com
medicine forum Guru
Joined: 27 Dec 2005
Posts: 470
|
| Posted: Thu May 18, 2006 7:07 pm Post subject:
Re: Maybe one day we'll be able to trust journal editors?
|
|
|
Pastor Kutchie wrote:
| Quote: | Andrew B. Chung, MD/PhD wrote:
Susan wrote:
http://www.medscape.com/viewarticle/532326?sssdmh=dm1.193479&src=nldne
""In order for the articles in medical journals to be free of advertiser
influence, there cannot be continued reliance on pharmaceutical
companies as the sole advertisers," Dr. Adriane Fugh-Berman of the
Georgetown University School of Medicine in Washington, DC, the study's
lead author, told Reuters Health."
This proves that the only Person you can trust is LORD GOD Almighty.
No, it proves that those who make money out of the treatment of the
sick have an inherent conflict of interest.
|
It seems that you are unaware of the fact that the only Person Who has
been documented to have received no pay either in the form of money or
barter for the effective treatment and curing of the sick is LORD Jesus
Christ. Moreover, HE even treated the sick on weekends plus made
housecalls :-)
Still praying for your soul, dear neighbor.
Prayerfully in Christ's amazing love,
Andrew
http://tinyurl.com/mpuzr |
|
| Back to top |
|
|
Google
|
|
| Back to top |
|
|
|
|
The time now is Thu Jun 23, 2011 6:29 am | All times are GMT
|
|
Copyright © 2004-2005 DeniX Solutions SRL
|
|
Other DeniX Solutions sites:
email marketing campaigns ,
electronics forum,
Science forum,
Unix/Linux blog,
Unix/Linux documentation,
Unix/Linux forums
|
Powered by phpBB © 2001, 2005 phpBB Group
|
|
FAQ
Search
Memberlist
Usergroups
Profile
Log in to check your private messages
Log in
Forum index
»
Medicine forums
»
cardiology
